discover.bioduro-sundia.com Open in urlscan Pro
52.54.96.194  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Download the exclusive e-book
Is this email not displaying correctly?
View it in your browser.


 

HOW DOES A HIGHLY CLINICALLY TRANSLATABLE NASH MODEL HELP NEW DRUG DISCOVERY?


In July, Madrigal Pharmaceuticals' rolling review for Resmetirom sparked
optimism in the NASH drug R&D sector. Simultaneously, the rise of GLP-1 receptor
agonist treatments by Novo Nordisk, Eli Lilly, and MSD highlights the industry's
focus on combatting NAFLD/NASH.

John Liu, our Head of Pharmacology, brings over 15 years of expertise in
immunology, inflammation, and metabolic disease models. In the 13-page e-book,
he sheds light on industry challenges and the potential for a clinically
translatable NASH model to offer solutions. 

Download the e-book today to learn more! 

Download now!

 

DR. JOHN LIU

Head of Pharmacology at BioDuro-Sundia

Download the exclusive e-book today!

Download now!

Copyright © 2023, All rights reserved.

Our mailing address is:

BioDuro-Sundia
9601 Jeronimo Road
Irvine, California 92618

 
follow us on LinkedIn  | update subscription preferences